Health care stocks were mixed Wednesday afternoon with the NYSE Health Care Index down 0.1% and the Health Care Select Sector SPDR Fund (XLV) adding 0.3%.
The iShares Biotechnology ETF (IBB) rose 1.2%.
In corporate news, CVS Health (CVS) shares jumped past 12% as a Q3 revenue beat overshadowed an earnings miss.
AstraZeneca (AZN) four senior executives in China, including two former employees, are being investigated for alleged violations of Chinese laws on drug importation and data privacy, Bloomberg reported, citing the company. AstraZeneca shares were falling 3.2%.
Novo Nordisk (NVO) reported Q3 earnings Wednesday of 6.12 Danish kroner ($0.88) per diluted American depositary share, up from 5 kroner a year earlier and above the expectation of three analysts polled by Capital IQ calling for 5.95 kroner. Q3 net sales were 71.31 billion kroner, up from 58.73 billion kroner in the year-ago period but below the Capital IQ consensus analyst estimate of 71.87 billion kroner. Novo shares shed 3.7%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.